EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:50514 - vasoconstrictor agent
| ChEBI ID | CHEBI:50514 |
| ChEBI Name | vasoconstrictor agent |
| Stars | |
| Definition | Drug used to cause constriction of the blood vessels. |
| Last Modified | 25 April 2025 |
| Submitter | Inma Spiteri |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| vasoconstrictor agent (CHEBI:50514) is a cardiovascular drug (CHEBI:35554) |
| Incoming Relation(s) |
| (R)-adrenaline (CHEBI:28918) has role vasoconstrictor agent (CHEBI:50514) |
| (R)-noradrenaline (CHEBI:18357) has role vasoconstrictor agent (CHEBI:50514) |
| (−)-ephedrine (CHEBI:15407) has role vasoconstrictor agent (CHEBI:50514) |
| (8S,9R)-EET (CHEBI:132302) has role vasoconstrictor agent (CHEBI:50514) |
| P1,P5-bis(5'-adenosyl) pentaphosphate (CHEBI:28898) has role vasoconstrictor agent (CHEBI:50514) |
| P1,P6-bis(5'-adenosyl)hexaphosphate (CHEBI:63689) has role vasoconstrictor agent (CHEBI:50514) |
| L-dopa (CHEBI:15765) has role vasoconstrictor agent (CHEBI:50514) |
| 8-epi-prostaglandin E2 (CHEBI:131888) has role vasoconstrictor agent (CHEBI:50514) |
| 8-epi-prostaglandin F2α (CHEBI:34505) has role vasoconstrictor agent (CHEBI:50514) |
| acetazolamide (CHEBI:27690) has role vasoconstrictor agent (CHEBI:50514) |
| albumin human (CHEBI:749447) has role vasoconstrictor agent (CHEBI:50514) |
| almotriptan (CHEBI:520985) has role vasoconstrictor agent (CHEBI:50514) |
| almotriptan malate (CHEBI:53781) has role vasoconstrictor agent (CHEBI:50514) |
| ampreloxetine (CHEBI:757112) has role vasoconstrictor agent (CHEBI:50514) |
| ampreloxetine hydrochloride (CHEBI:757780) has role vasoconstrictor agent (CHEBI:50514) |
| angiotensin II (CHEBI:48432) has role vasoconstrictor agent (CHEBI:50514) |
| atomoxetine (CHEBI:127342) has role vasoconstrictor agent (CHEBI:50514) |
| atropine (CHEBI:16684) has role vasoconstrictor agent (CHEBI:50514) |
| caesium chloride (CHEBI:63039) has role vasoconstrictor agent (CHEBI:50514) |
| caffeine (CHEBI:27732) has role vasoconstrictor agent (CHEBI:50514) |
| carbidopa (CHEBI:3395) has role vasoconstrictor agent (CHEBI:50514) |
| carbocyclic thromboxane A2 (CHEBI:139043) has role vasoconstrictor agent (CHEBI:50514) |
| celecoxib (CHEBI:41423) has role vasoconstrictor agent (CHEBI:50514) |
| cocaine (CHEBI:27958) has role vasoconstrictor agent (CHEBI:50514) |
| deglymidodrine (CHEBI:73248) has role vasoconstrictor agent (CHEBI:50514) |
| dihydroergotamine (CHEBI:4562) has role vasoconstrictor agent (CHEBI:50514) |
| dihydroergotamine mesylate (CHEBI:59756) has role vasoconstrictor agent (CHEBI:50514) |
| dihydroergotamine tartrate (CHEBI:59757) has role vasoconstrictor agent (CHEBI:50514) |
| droxidopa (CHEBI:31524) has role vasoconstrictor agent (CHEBI:50514) |
| edrophonium (CHEBI:251408) has role vasoconstrictor agent (CHEBI:50514) |
| eletriptan (CHEBI:50922) has role vasoconstrictor agent (CHEBI:50514) |
| eletriptan hydrobromide (CHEBI:61176) has role vasoconstrictor agent (CHEBI:50514) |
| ergotamine (CHEBI:64318) has role vasoconstrictor agent (CHEBI:50514) |
| FE201874 (CHEBI:234125) has role vasoconstrictor agent (CHEBI:50514) |
| felypressin (CHEBI:60564) has role vasoconstrictor agent (CHEBI:50514) |
| galanthamine (CHEBI:42944) has role vasoconstrictor agent (CHEBI:50514) |
| human immunoglobulin g (CHEBI:749498) has role vasoconstrictor agent (CHEBI:50514) |
| ibuprofen (CHEBI:5855) has role vasoconstrictor agent (CHEBI:50514) |
| indometacin (CHEBI:49662) has role vasoconstrictor agent (CHEBI:50514) |
| isoproterenol (CHEBI:747921) has role vasoconstrictor agent (CHEBI:50514) |
| ivabradine (CHEBI:85966) has role vasoconstrictor agent (CHEBI:50514) |
| leukotriene B4 (CHEBI:15647) has role vasoconstrictor agent (CHEBI:50514) |
| metaraminol (CHEBI:6794) has role vasoconstrictor agent (CHEBI:50514) |
| methyldopa (racemic) (CHEBI:748067) has role vasoconstrictor agent (CHEBI:50514) |
| methylphenidate (CHEBI:6887) has role vasoconstrictor agent (CHEBI:50514) |
| methysergide (CHEBI:584020) has role vasoconstrictor agent (CHEBI:50514) |
| metoclopramide (CHEBI:107736) has role vasoconstrictor agent (CHEBI:50514) |
| midodrine (CHEBI:6933) has role vasoconstrictor agent (CHEBI:50514) |
| midodrine hydrochloride (CHEBI:31847) has role vasoconstrictor agent (CHEBI:50514) |
| modafinil (CHEBI:31859) has role vasoconstrictor agent (CHEBI:50514) |
| mometasone (CHEBI:6970) has role vasoconstrictor agent (CHEBI:50514) |
| moxifloxacin (CHEBI:63611) has role vasoconstrictor agent (CHEBI:50514) |
| Moxonidine (CHEBI:7009) has role vasoconstrictor agent (CHEBI:50514) |
| naratriptan (CHEBI:7478) has role vasoconstrictor agent (CHEBI:50514) |
| nitroprusside (CHEBI:7596) has role vasoconstrictor agent (CHEBI:50514) |
| oxymetazoline (CHEBI:7862) has role vasoconstrictor agent (CHEBI:50514) |
| oxymetazoline hydrochloride (CHEBI:7863) has role vasoconstrictor agent (CHEBI:50514) |
| PD123319 (CHEBI:61014) has role vasoconstrictor agent (CHEBI:50514) |
| phenylephrine (CHEBI:8093) has role vasoconstrictor agent (CHEBI:50514) |
| propranolol (CHEBI:8499) has role vasoconstrictor agent (CHEBI:50514) |
| pseudoephedrine (CHEBI:51209) has role vasoconstrictor agent (CHEBI:50514) |
| Pyridostigmine (CHEBI:8665) has role vasoconstrictor agent (CHEBI:50514) |
| Pyridostigmine bromide (CHEBI:8666) has role vasoconstrictor agent (CHEBI:50514) |
| rivastigmine tartrate (CHEBI:64358) has role vasoconstrictor agent (CHEBI:50514) |
| rizatriptan (CHEBI:48273) has role vasoconstrictor agent (CHEBI:50514) |
| sumatriptan (CHEBI:10650) has role vasoconstrictor agent (CHEBI:50514) |
| sumatriptan succinate (CHEBI:64359) has role vasoconstrictor agent (CHEBI:50514) |
| tetrahydrozoline hydrochloride (CHEBI:9492) has role vasoconstrictor agent (CHEBI:50514) |
| tetrahydrozoline nitrate (CHEBI:145570) has role vasoconstrictor agent (CHEBI:50514) |
| tranylcypromine (CHEBI:9652) has role vasoconstrictor agent (CHEBI:50514) |
| tyramine (CHEBI:15760) has role vasoconstrictor agent (CHEBI:50514) |
| U0126 (CHEBI:90693) has role vasoconstrictor agent (CHEBI:50514) |
| U0126.EtOH (CHEBI:90692) has role vasoconstrictor agent (CHEBI:50514) |
| yohimbine (CHEBI:10093) has role vasoconstrictor agent (CHEBI:50514) |
| zolmitriptan (CHEBI:10124) has role vasoconstrictor agent (CHEBI:50514) |
| α-methylnoradrenaline (CHEBI:141146) has role vasoconstrictor agent (CHEBI:50514) |